Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

GPCR - Structure Therapeutics Inc. Financial... | Finranks

Home

/

GPCR

S

Structure Therapeutics Inc. (GPCR)

NGM – Real Time Price. Currency in USD

52.89

+0.76 (1.46%)

Market open: Aug 12, 2026, 10:12 AM EDT

52.00

-0.13 (-0.25%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

0

0

Cost of goods sold

-4M

-3M

-949K

-623K

Gross Profit

-4M

-3M

-949K

-623K

Operating expenses (excl. COGS)

-284M

-156M

-102M

-52M

Operating Income

-288M

-158M

-103M

-52M

Non-operating income, total

147M

36M

13M

1M

Pretax income

-141M

-122M

-89M

-51M

Equity in earnings

0

0

0

0

Taxes

-516K

-310K

-236K

-17K

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-142M

-123M

-90M

-51M

Discontinued operations

0

0

0

0

Net income

-142M

-123M

-90M

-51M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

2M

Name

2025

2024

2023

2022

Total assets

1.58B+75.3%

903M+87.4%

482M+392.6%

98M

Total current assets

1.57B

891M

474M

93M

Total non-current assets

14M

12M

8M

5M

Total liabilities

68M+75.5%

38M+32.5%

29M+123.3%

13M

Total current liabilities

63M

36M

25M

13M

Total non-current liabilities

4M

2M

4M

0

Total equity

1.52B

865M

453M

85M

Total liabilities & shareholders' equities

1.58B

903M

482M

98M

Total debt

6M+68.0%

4M-29.2%

5M+1997.3%

260K

Name

2025

2024

2023

2022

Cash from operating activities

-223M

-117M

-79M

-46M

Cash from investing activities

90M

-359M

-268M

-62M

Cash from financing activities

765M

516M

451M

29M

Free cash flow

-226M-91.9%

-118M-44.6%

-82M-76.5%

-46M